SIRT7 orchestrates melanoma progression by simultaneously promoting cell survival and immune evasion via UPR

Xiuli Yi1, Huina Wang1, Yuqi Yang1

  • 1Department of Dermatology, Xijing Hospital, Fourth Military Medical University, No 127 of West Changle Road, Xi'an, Shaanxi, 710032, China.

Insights

SIRT7 promotes melanoma growth and immune evasion by activating the unfolded protein response. Suppressing SIRT7 may enhance immunotherapy effectiveness against this lethal skin cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Melanoma remains a lethal skin cancer with suboptimal patient prognosis despite advances in therapy.
  • The tumor microenvironment presents significant stress to melanoma cells.
  • SIRT7, a NAD+-dependent deacetylase, maintains cell homeostasis, but its role in melanoma under stress is unclear.

Purpose of the Study:

  • To investigate the role of SIRT7 in melanoma progression and immune evasion under stressful conditions.
  • To elucidate the underlying molecular mechanisms by which SIRT7 influences melanoma cell survival and the tumor microenvironment.

Main Methods:

  • Assessed SIRT7 expression levels in sirtuins family under stress.
  • Utilized in vitro and in vivo models to evaluate the effects of SIRT7 deficiency on melanoma.
  • Investigated SIRT7's impact on the IRE1α-XBP1 axis, ERK signaling, and cytokine secretion.
  • Examined SIRT7's regulation of SMAD4 and TGF-β signaling.
  • Analyzed SIRT7's role in PD-L1 expression and anti-tumor immunity.
  • Evaluated combination therapy of SIRT7 suppression and anti-PD-1 blockade.

Main Results:

  • SIRT7 expression significantly increased under stress and was the highest among sirtuins.
  • SIRT7 deficiency led to increased tumor cell death under stress and suppressed melanoma growth in vivo.
  • SIRT7 activated the IRE1α-XBP1 pathway, enhancing pro-survival ERK signaling and tumor-promoting cytokines.
  • SIRT7 de-acetylated SMAD4, antagonizing TGF-β signaling and promoting IRE1α-XBP1 activation.
  • SIRT7 upregulation promoted PD-L1 expression, contributing to immune evasion.
  • Combined SIRT7 suppression and anti-PD-1 blockade showed synergistic therapeutic effects.

Conclusions:

  • SIRT7 drives melanoma progression by promoting cell survival and immune evasion through the unfolded protein response.
  • SIRT7 directly impacts key signaling pathways, including IRE1α-XBP1, ERK, and TGF-β.
  • SIRT7 inhibition represents a potential therapeutic strategy to overcome resistance and enhance melanoma immunotherapy.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.5K